Cargando…
Virus-mediated gene transfer to induce therapeutic angiogenesis: Where do we stand?
The potential to induce therapeutic angiogenesis through gene transfer has engendered much excitement as a possible treatment for tissue ischemia. After 10 years of clinical experimentation, however, it now appears clear that several crucial issues are still to be resolved prior to achieving clinica...
Autor principal: | Giacca, Mauro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676804/ https://www.ncbi.nlm.nih.gov/pubmed/18203421 |
Ejemplares similares
-
The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016) -
Where Do We Stand?
Publicado: (1891) -
Spinal Muscular Atrophy Therapeutics: Where do we Stand?
por: d’Ydewalle, Constantin, et al.
Publicado: (2015) -
Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)